MedTrace Logo

Effect of MET on Meralgia Paraesthesia Postpartum "Muscle Energy Technique"

NCT04747119 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-02-10

No results posted yet for this study

Summary

To investigate the effect of muscle energy technique on Femoral meralgia paraesthesia in a postpartum female. BACKGROUND: meralgia paraesthesia is one of the serious disorders in the postpartum female which results in pain and less physical activities.

………HYPOTHESES:

This study hypothesized that:

muscle energy technique will have a significant effect on Femoral meralgia paraesthesia in postpartum female

Conditions

  • Meralgia Paresthetica
  • Femoral Neuropathy

Interventions

OTHER

muscle energy technique

the patient was supine and the therapist fix the lower limb of the affected side then ask the patient to perform isometric contraction for abductors maintained for 3-5 seconds, then the patient was instructed to stop, exhale and relax then the therapist perform further adducted the patient's knee of the affected side as a stretching exercise for Three to five repetitions of these directions were performed.

OTHER

conventional selected physical therapy

1. life style modification 2. Transcutaneous electrical nerve stimulation (TENS) 3. Flexibility stretching exercises to the hip flexors

Sponsors & Collaborators

  • October 6 University

    lead OTHER

Principal Investigators

  • Lama Saad Mahmoud, PHD · October 6 University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2020-12-30
Completion
2021-01-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04747119 on ClinicalTrials.gov